Researching Corporations and Global Health Governance

An Interdisciplinary Guide

Häftad, Engelska, 2016

799 kr

Beställningsvara. Skickas inom 5-8 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

The profound changes to the world economy since the late twentieth century have been characterised by a growth in the number and size of transnational corporations. In this context, there is now increasing evidence of unprecedented reversals in health indicators among populations around the world. Research in this area has focused on documenting the global health impacts arising from the economic activity of corporations. The challenge for public health researchers is to understand the ways in which corporations are regulated by, and participate in global health governance and implications for health and well-being across the globe. This book is an introductory guide to conducting research on the role of corporations in global health governance from a range of disciplinary perspectives and gives an overview of different approaches, methodologies and data sources. Also, for case studies providing interdisciplinary empirical analysis of the impact of corporations on global health and global health governance, see the partner volume: http://www.rowmaninternational.com/books/case-studies-on-corporations-and-global-health-governance

Produktinformation

Utgivningsdatum2016-12-07
Mått152 x 229 x 22 mm
Vikt472 g
FormatHäftad
SpråkEngelska
Antal sidor314
FörlagBloomsbury Publishing PLC
ISBN9781783483600

Tillhör följande kategorier

Kelley Lee is Tier 1 Canada Research Chair in Global Health Governance and Professor in the Faculty of Health Sciences, Simon Fraser University. She has published more than 100 peer-reviewed papers, 50 book chapters and 14 books including Global Health and International Relations (2012), Asia’s Role in Governing Global Health (2012) and Transformations in Global Health Governance (2014).Dr. Benjamin Hawkins is a Lecturer in Global Health Policy at the London School of Hygiene and Tropical Medicine, teaching global health policy. His current research focuses on the role of research evidence and corporate actors in health policy making at the national and global levels and the impact in regional and bilateral trade and investment agreements on health. In particular his work focuses on the global alcohol and tobacco industries. Prior to entering academia he worked in sales and marketing for the alcohol producer Diageo.

Preface / List of acronyms / List of illustrations / 1. Corporations and global health governance: A research agenda, Lee, Hawkins and Wiist / PART I: DISCIPLINARY APPROACHES TO ANALYSING CORPORATIONS / 2. Political science, Hawkins / 3. International political economy, Eckhardt / 4. Social Policy, Holden and Farnsworth / 5. Historical analysis, MacKenzie / 6. Criminology, Michalowski / 7. Anthropology, Parker and Kenworthy / 8. Public health, Wipfli and Mack / 9. Development Studies, Carnegie / 10. Media analysis and corporate communication, Kline / PART II: METHODS AND DATA SOURCES FOR ANALYSING CORPORATIONS / 11. Interviewing key informants from the corporate sector, Hawkins and Cassidy / 12. The role of ethnography in analysing corporations, Carrillo Botero / 13. Oral history, Stevenson / 14. Participation of corporations in international organizations, Derman / 15. Studying the influence of corporations on democratic processes, Wiist / 16. Analysing corporate documents, MacKenzie and Holden / 17. Social media research methods, Freeman / 18. Making use of business and financial data, Lee / 19. Using freedom of information requests, Freeman / 20. Tracking down and using grey literature, Taylor and Sullivan / 21. Legal and ethical considerations, Lee, Hawkins & Silva / 22. Developing a data management plan, Carrillo Botero and Fang /About the Contributors / Index

No plan to improve global health can succeed without defining appropriate roles for transnational corporations. Researching Corporations and Global Health Governance: An Interdisciplinary Guide provides essential guidance to neophyte and experienced researchers on the methods, data sources and research designs that can provide policy makers with the evidence they need to protect public health from harmful corporate practices.